Changeflow GovPing Healthcare & Life Sciences Endoscopic Puncture Needle Design USD1124338S1 ...
Routine Rule Added Final

Endoscopic Puncture Needle Design USD1124338S1 by Olympus

Favicon for changeflow.com USPTO Patent Grants - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

The United States Patent and Trademark Office granted Design Patent USD1124338S1 to OLYMPUS MEDICAL SYSTEMS CORP. for an endoscopic puncture needle on April 28, 2026. The patent, with a single claim, covers the ornamental design of the endoscopic puncture needle device; the underlying application was filed on May 19, 2023. The design patent provides Olympus with 15 years of exclusive rights to the ornamental design as of the grant date.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

USPTO classification A61B covers diagnostic, surgical, and identification instruments: imaging systems, surgical robots, biosignal sensors, endoscopes, biopsy tools, surgical navigation, wearable diagnostic patches, and any device that goes near a patient for measurement or intervention. This feed tracks every patent grant in A61B, around 475 a month, with the patent number, title, applicant, inventor names, and abstract. Watch this if you compete in medical devices, file freedom-to-operate analyses, scout acquisition targets in surgical robotics or imaging, or track what hospitals' R&D arms are quietly patenting. GovPing pulls each grant as it publishes on the USPTO's official feed.

Notice an inaccuracy or want this record removed? Email corrections@changeflow.com . We respond within 48 hours and honor reasonable requests. See our editorial standards .

What changed

The USPTO issued Design Patent USD1124338S1 to OLYMPUS MEDICAL SYSTEMS CORP., granting exclusive ornamental design rights for an endoscopic puncture needle. The patent contains one claim and the design will be protected for 15 years from the issue date.

Manufacturers of endoscopic medical devices should review this design grant to assess whether their existing or planned needle products could create infringement exposure under this design patent. Licensing inquiries may be directed to the assignee for any competing designs that fall within the claimed ornamental scope.

Archived snapshot

Apr 28, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Endoscopic puncture needle

Design USD1124338S1 Kind: S1 Apr 28, 2026

Assignee

OLYMPUS MEDICAL SYSTEMS CORP.

Inventors

Ryoma Tamura, Shuntaro Hattori

CPC Classifications

A61B 17/06 A61B 17/3211 A61B 17/3478 A61B 2017/00349 A61B 2017/047

Filing Date

2023-05-19

Application No.

29876323

Claims

1

View original document →

Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 28th, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Design patent prosecution Medical device IP
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!